Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Cognitive performance as a behavioral phenotype associated with cocaine self-administration in female and male socially housed monkeys
    Published on 2024-05-17
    2 years ago
  • Pre- and postsynaptic signatures in the prelimbic cortex associated with “alcohol use disorder” in the rat
    Published on 2024-05-16
    2 years ago
  • Common side effects of MDMA-assisted psychotherapy
    Published on 2024-05-13
    2 years ago
  • Early life stress is associated with greater negative emotionality and peripheral inflammation in alcohol use disorder
    Published on 2024-05-13
    2 years ago
  • Intermittent theta-burst stimulation to the right dorsolateral prefrontal cortex may increase potentiated startle in healthy individuals
    Published on 2024-05-13
    2 years ago
  • Ventral subiculum promotes wakefulness through several pathways in male mice
    Published on 2024-05-11
    2 years ago
  • Variants of the P3 event-related potential operate as indicators of distinct mechanisms contributing to problematic alcohol use
    Published on 2024-05-11
    2 years ago
« Previous 1 … 58 59 60 61 62 … 143 Next »
Journal of Psychopharmacology
  • Commentary on Cochrane review: “Ketamine and other glutamate receptor modulators for depression in adults with unipolar major depressive disorder”
    Published on 2022-10-11
    3 years ago
  • Pharmaco-fUS in cognitive impairment: Lessons from a preclinical model
    Published on 2022-10-07
    3 years ago
  • Associations between MDMA/ecstasy use and physical health in a U.S. population-based survey sample
    Published on 2022-10-03
    3 years ago
  • The low risk for early renal damage during lithium treatment has not changed over time
    Published on 2022-09-19
    3 years ago
  • Individual differences in cocaine-induced conditioned place preference in male rats: Behavioral and transcriptomic evidence
    Published on 2022-09-19
    3 years ago
  • The association between N-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controls
    Published on 2022-09-19
    3 years ago
  • Deepening our understanding of psychedelics by expanding psychedelic data collection in the United States National Survey on Drug Use and Health
    Published on 2022-09-16
    3 years ago
« Previous 1 … 58 59 60 61 62 … 134 Next »
European Neuropsychopharmacology
  • Cognitive and clinical correlates of resting-state fMRI in adults with gambling disorder
    Published on 2023-01-13
    3 years ago
  • The efficacy of lumateperone on symptoms of depression in bipolar I and bipolar II disorder: Secondary and post hoc analyses
    Published on 2023-01-13
    3 years ago
  • Clinical and developmental characteristics of cognitive subgroups in a transdiagnostic sample of schizophrenia spcectrum disorders and bipolar disorder
    Published on 2023-01-13
    3 years ago
  • Second-generation antipsychotics and seizures – a systematic review and meta-analysis of serious adverse events in randomized controlled trials
    Published on 2023-01-13
    3 years ago
  • The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings
    Published on 2023-01-13
    3 years ago
  • Neurochemical mechanisms of deep brain stimulation for depression in animal models
    Published on 2023-01-13
    3 years ago
  • Who has poor insight, my patient suffering from schizophrenia or myself?
    Published on 2023-01-13
    3 years ago
« Previous 1 … 58 59 60 61 62 … 154 Next »

   Pharma Pub